Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Completed · Phase 2

Conditions studied: Breast Cancer, Metastases

In brief

The purpose of this research study is to assess the response rate of the investigational drug BMS-247550 (Ixabepilone) in women with metastatic breast cancer who are refractory to an anthracycline, a taxane, and capecitabine.

Key facts

Study ID

NCT00080262

Run by

R-Pharm

People needed

125

Starts

2004-02-01

Expected to finish

2006-12-01

Last updated by the study team

2017-01-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have received all 3 drugs- an anthracycline, taxane, and capecitabine (alone or in combination) and be resistant
• No more than 3 prior chemotherapy regimens in the metastatic setting
• Must have at least one target lesion that is radiographically measurable
• Good performance status
• No history of or current brain or leptomeningeal disease

Where it is running

• Local Institution — La Verne, California, United States
• Local Institution — Meriden, Connecticut, United States
• Local Institution — Jacksonville, Florida, United States
• Local Institution — Baltimore, Maryland, United States
• Local Institution — Boston, Massachusetts, United States
• Local Institution — New York, New York, United States
• Local Institution — Asheville, North Carolina, United States
• Local Institution — Charlotte, North Carolina, United States
• Local Institution — Pittsburgh, Pennsylvania, United States
• Local Institution — Providence, Rhode Island, United States
• Local Institution — Chattanooga, Tennessee, United States
• Local Institution — Jackson, Tennessee, United States
• Local Institution — Knoxville, Tennessee, United States
• Local Institution — Nashville, Tennessee, United States
• Local Institution — Houston, Texas, United States
• Local Institution — San Antonio, Texas, United States
• Local Institution — Salt Lake City, Utah, United States
• Local Institution — Buenos Aires, Argentina
• Local Institution — Santa Fe, Argentina
• Local Institution — Montreal, Quebec, Canada
• Local Institution — Besançon, France
• Local Institution — Bobigny, France
• Local Institution — Clermont-Ferrand, France
• Local Institution — Dijon, France
• Local Institution — Lyon, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.